Takeda is introducing wearable devices in its research into the management of IBD. The program, named iBData, is being conducted with Texas Digestive Disease Consultants (TDDC) and Vanderbilt University Medical Center (VUMC).
The program goal is to “allow patients with IBD to track their symptoms and lifestyle factors with wearable watch technology.” The data will be presented in specialized reports to help patients and physicians communicate and enhance care.
“At Takeda, part of what fuels our ongoing dedication to advanced research in the field of gastroenterology is our deep understanding of the challenges that dictate unique needs for both patients and physicians managing IBD,” explained Stephanie Brown, vice president, head, Specialty Business Unit, Takeda. “iBData leverages the remarkable capabilities available today when wearable technologies and medicine converge, in an effort to help overcome these challenges. This innovative pilot program will explore new ways to transform care by generating novel insights into the patient experience that physicians can directly utilize.”
This story illustrates how progressive pharma companies are leveraging new mHealth technologies to enhance their “beyond the pill” offerings.
Source: Takeda Press Release
This story first appeared in the Klick Wire, delivered 7AM every Monday. Sign up to get the Wire today!